GLOW Blend 70mg | 99.86% Purity

99.86% Purity Avg. mass 66.19 mg

The GLOW Protocol is a proprietary three-peptide research blend combining GHK-Cu, TB-500, and BPC-157 — formulated to target convergent pathways in tissue regeneration, extracellular matrix remodeling, and inflammatory resolution.

GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It functions as a signaling molecule that activates over 4,000 genes involved in tissue remodeling — upregulating collagen I and III synthesis, elastin production, glycosaminoglycan deposition, and decorin expression while simultaneously suppressing pro-inflammatory cytokines (TGF-β, TNF-α) and stimulating metalloproteinase activity for controlled matrix turnover. In preclinical models, GHK-Cu has demonstrated potent wound-healing, antioxidant, and anti-fibrotic activity.

TB-500 (Thymosin Beta-4) is a 43–amino acid peptide that serves as the primary intracellular G-actin sequestering molecule — directly regulating actin polymerization, cell migration, and angiogenesis at injury sites. Its role in downregulating myofibroblast differentiation makes it a key compound in scar-reduction and fibrosis research.

BPC-157 (Body Protection Compound-157) is a 15–amino acid gastric peptide that activates FAK-paxillin and JAK-2/STAT-3 signaling pathways, promoting growth factor expression (VEGF, EGF, FGF), nitric oxide–mediated vascular repair, and cytoprotection across musculoskeletal, gastrointestinal, and neurological tissue models.

Blend rationale: Each component operates through distinct yet interconnected repair mechanisms — GHK-Cu drives matrix architecture and gene-level remodeling, TB-500 mobilizes cellular migration and vascular formation, and BPC-157 orchestrates growth factor signaling and inflammation control. Together, the GLOW Protocol enables multi-axis regenerative research that no single peptide can replicate.